New combo treatment for prostate cancer and BPH passes early safety check
NCT ID NCT05311527
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 29 times
Summary
This study tested whether using the UroLift system before targeted radiation is safe for men with both prostate cancer and an enlarged prostate (BPH). Fifteen men participated, and researchers monitored side effects within 90 days of treatment. The goal was to see if this combination could ease urinary symptoms without causing extra harm.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.